Author

D. T. Bishop

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:drug response / drug discovery· 1 Research Focus:fine-mapping· 1 Assay:proteomics· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Droop· 1 shared A. Greenhough· 1 shared A. Gsur· 1 shared A. Nounu· 1 shared A. T. Chan· 1 shared A. Trower· 1 shared C. Castaneda-Garcia· 1 shared C. D. Robles-Espinoza· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

A. Droop

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Fine-mapping of melanoma-associated genomic regions identifies novel causal SNPs in the MTAP/CDKN2A and CASP8 loci

C. Castaneda-Garcia, V. Iyer, J. Nsengimana, A. Trower, A. Droop, K. M. Brown, J. Choi, T. Zhang, M. Harland, J. A. Newton-Bishop, D. T. Bishop, D. J. Adams, M. M. Iles, C. D. Robles-Espinoza

The paper fine-maps melanoma-associated genomic regions to identify novel causal SNPs in the MTAP/CDKN2A and CASP8 loci using sequencing, variant filtering, and functional assays.

medRxiv · Jul 17, 2021 · PreprintGenetic & Genomic Medicine

A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer

A. Nounu, A. Greenhough, K. J. Heesom, R. C. Richmond, J. Zheng, S. J. Weinstein, D. Albanes, J. A. Baron, J. L. Hopper, J. C. Figueiredo, P. A. Newcomb, N. M. Lindor, G. Casey, E. A. Platz, L. Le Marchand, , G. Rennert

This study combines proteomics and Mendelian randomization to identify aspirin-targeted proteins associated with reduced colorectal cancer risk.

bioRxiv · Aug 14, 2020Cancer Biology